|Articles|February 1, 2012
- Pharmaceutical Executive-02-01-2012
- Volume 0
- Issue 0
Pharmaceutical Executive Digital Edition - February 2012
Brand of the Year : Abbott's Humira
Advertisement
Articles in this issue
over 14 years ago
How to Choose a Medical Animatorover 14 years ago
Money for Nothing, Patents for Free?over 14 years ago
Trying Trials at GC-2over 14 years ago
Prizing the Eye : Brent Saunders, CEO Bausch + Lombover 14 years ago
Brand Success: It's Not Serendipityover 14 years ago
Brazil Report: A Bold Player Bloomsover 14 years ago
Of Farms, Beaches … and Genericsover 14 years ago
FDA Social Media Guidelines: Irresponsible?over 14 years ago
Time to Appoint a 'Chief Patient Officer'?over 14 years ago
Japanese Knowledge Brought to BrazilNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Boehringer Ingelheim Expands Immunology Pipeline With Preclinical Antibody Licensing Deal
2
Marty Makary Out as FDA Commissioner: Report
3
The Insight Gap: Biopharma’s Hidden Risk in the Race Against the Patent Cliff
4
From Consulting to Venture Capital: A Q&A with Gibb Witham, President of Hack The Box
5